CORAL SPRINGS, Florida, July 18, 2013 /PRNewswire/ --
FinancialNewsMedia.com issues market news updates for today's active biotech companies: Alliqua, Inc. (OTCQB: ALQA), Transition Therapeutics Inc. (NASDAQ: TTHI), Organovo Holdings, Inc. (NYSE: ONVO), MiMedx Group, Inc. (NASDAQ: MDXG), Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX)
Alliqua, Inc. (OTCQB: ALQA) Headline: Alliqua's SilverSeal Dressing Shown to Improve Surgical Wound Outcomes in Clinical Study. ALQA today announced the results from a post-marketing study to assess surgical wound outcomes in patients who have undergone foot and ankle surgery. In this study, Alliqua's SilverSeal® dressing was shown to have a lower incidence of incision complications, including infection, and a greater reduction in scar length compared to standard petroleum-based dressing. Study results are being presented at the annual meeting of the American Orthopaedic Foot & Ankle Society, which is being held in Hollywood, Florida July 17-20. Stephen A. Brigido, DPM, director of the foot and ankle fellowship at the Coordinated Health Foot and Ankle Center and a primary investigator in the study, stated, "The results from this study are consistent with our preliminary findings reported earlier this year and indicate SilverSeal has potential to not only improve post-surgical incision healing but to reduce healthcare expenditures related to incision complications." To read the entire press release, please go to http://www.financialnewsmedia.com/stock-investing-business-investing-news/
|SOURCE FN Media Group LLC|
Copyright©2012 PR Newswire.
All rights reserved